TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.